Free Access
Med Sci (Paris)
Volume 18, Number 1, Janvier 2002
Page(s) 86 - 90
Section M/S Revues : Mini-Synthéses
Published online 15 January 2002
  1. Martucci CP, Fishman J. P450 enzymes of estrogen metabolism. Pharmacol Ther 1993; 57 : 237–57. [Google Scholar]
  2. Ozawa Y Higashiyama T, Shimizu Y, Yarborough C. Multiple functions of aro-matase and the active site structure; aromatase is the placental estrogen 2-hydroxylase. J Steroid Biochem Mol Biol 1993; 44 : 469–80. [Google Scholar]
  3. Weisz J, Bui QD, Roy D, Liehr JG. Elevated 4-hydroxylation of estradiol by hamster kidney microsomes: a potential pathway of metabolic activation of estrogens. Endocrinology 1992; 131 : 655–61. [Google Scholar]
  4. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, Sutter TR. 17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 1996; 93: 9776–81. [Google Scholar]
  5. Stresser DM, Kupfer D. Catalytic characteristics of CYP3A4: requirement for a phenolic function in ortho hydroxylation of estradiol and mono-Odemethylated methoxychlor. Biochemistry 1997; 36 : 2203–10. [Google Scholar]
  6. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents-DNA adducts and mutations.J Natl Cancer Inst Monogr 2000; 27 : 75–93. [Google Scholar]
  7. Yager JD. Endogenous estrogens as carcinogens through metabolic activation. J Natl Cancer Inst Monogr 2000; 27: 67–73. [Google Scholar]
  8. Liehr JG, Roy D, Ari-Ulubelen A, Bui QD, Weisz J, Strobel HW. Effect of chronic estrogen treatment of Syrian hamsters on microsomal enzymes mediating formation of catecholestrogens and their redox cycling: implications for carcinoge-nesis. J Steroid Biochem 1990; 35 : 555–60. [Google Scholar]
  9. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Annu Rev Pharmacol Toxicol 1996; 36 : 203–32. [Google Scholar]
  10. Wang MY, Liehr JG. Identification of fatty acid hydroperoxide cofactors in the cytochrome P450-mediated oxidation of estrogens to quinone metabolites. Rôle and balance of lipid peroxides during estrogen-induced carcinogenesis.J Biol Chem 1994; 269, 284–91. [Google Scholar]
  11. Roy D, Strobel HW, Liehr JG. Cytochrome b5-mediated redox cycling of estrogen. Arch Biochem Biophys 1991; 285; 331–8. [Google Scholar]
  12. Li JJ, Li SA. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 1987; 46 : 1858–63. [Google Scholar]
  13. Liehr JG, Fang WF, Sirbasku DA, Ari-Ulubelen A. Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 1986; 24 : 353–6. [Google Scholar]
  14. Cavalieri EL, Stack DE, Devanesan PD, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997; 94 : 10937–42. [Google Scholar]
  15. Liehr JG, Ricci MJ, Jefcoate CR, Hannigan EV, Hokanson JA, Zhu BT. 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci USA 1995; 92 : 9220–4. [Google Scholar]
  16. Liehr JG, Ricci MJ. 4-Hydroxylation of estrogens as marker of human mammary tumors.Proc Natl Acad Sci USA 1996; 93 : 3294–6. [Google Scholar]
  17. Han X, Liehr JG. Microsomemediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis 1995; 16 : 2571–4. [Google Scholar]
  18. Creveling, C.R. Catechol-omethyltransferase: factors relating to the carcinogenic potential of catecholestrogens. Polycyclic Aromatic Compounds 1994; 125. [Google Scholar]
  19. Roy D, Weisz J, Liehr JG. The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogeninduced carcinogenesis. Carcinogenesis 1990; 11 : 459–62. [Google Scholar]
  20. Lesca P,Pineau T. Toxicité de la dioxine : rÔle des protéines “PAS”. Med Sci 1999; 15 : 1379–87 [Google Scholar]
  21. Coumoul X, Diry M, Robillot C, Barouki R. Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7. Cancer Res 2001; 61 : 3942–8. [Google Scholar]
  22. Lucier GW, Tritscher A, Goldsworthy T, et al. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis. Cancer Res 1991; 51 : 1391–7. [Google Scholar]
  23. Tritscher AM, Seacat AM, Yager JD, et al. Increased oxidative DNA damage in livers of 2,3,7,8-tetrachlorodibenzo-p-dioxin treated intact but not ovariectomi-zed rats. Cancer Lett 1996; 98 : 219–25. [Google Scholar]
  24. Jefcoate CR, Liehr JG, Santen RJ, et al. Tissuespecific synthesis and oxidative metabolism of estrogens.J Natl Cancer Inst Monogr 2000; 27 : 95–112. [Google Scholar]
  25. Bradlow HL, Hershcopf R, Martucci C, Fishman J. 16 alpha-hydroxylation of estradiol: a possible risk marker for breast cancer. Ann NY Acad Sci 1986; 464: 138–51. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.